000 01487 a2200409 4500
005 20250516194310.0
264 0 _c20141015
008 201410s 0 0 eng d
022 _a1932-6203
024 7 _a10.1371/journal.pone.0087942
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCruz, Nelly M
245 0 0 _aModifier genes as therapeutics: the nuclear hormone receptor Rev Erb alpha (Nr1d1) rescues Nr2e3 associated retinal disease.
_h[electronic resource]
260 _bPloS one
_c2014
300 _ae87942 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aEye Diseases, Hereditary
_xgenetics
650 0 4 _aGenetic Therapy
_xmethods
650 0 4 _aHumans
650 0 4 _aMice
650 0 4 _aMice, Transgenic
650 0 4 _aNuclear Receptor Subfamily 1, Group D, Member 1
_xbiosynthesis
650 0 4 _aOrphan Nuclear Receptors
_xbiosynthesis
650 0 4 _aRetinal Degeneration
_xgenetics
650 0 4 _aRetinitis Pigmentosa
_xgenetics
650 0 4 _aVision Disorders
_xgenetics
700 1 _aYuan, Yang
700 1 _aLeehy, Barrett D
700 1 _aBaid, Rinku
700 1 _aKompella, Uday
700 1 _aDeAngelis, Margaret M
700 1 _aEscher, Pascal
700 1 _aHaider, Neena B
773 0 _tPloS one
_gvol. 9
_gno. 1
_gp. e87942
856 4 0 _uhttps://doi.org/10.1371/journal.pone.0087942
_zAvailable from publisher's website
999 _c23517867
_d23517867